Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.
Artificial human organs, or organ-on-chip technologies, simulate a whole organ’s cell make up and physiology. They act as alternatives to animal models in drug safety testing, but until now they have not been used to test how infectious diseases interact with the organs.
Our work represents the next frontier in the use of this technology.
Dr Marcus Dorner Lead author
Now, researchers from Imperial are using this technology to determine how pathogens interact with artificial organs. They hope it will help us to better understand the resulting disease and develop new treatments.
In particular, the team used an artificial liver – originally developed at MIT, the University of Oxford, and biotechnology company CN Bio Innovations – and tested its response to hepatitis B virus infection.
Dr Marcus Dorner, lead author from Imperial’s Department of Medicine, said: “This is the first time that organ-on-a-chip technology has been used to test viral infections. Our work represents the next frontier in the use of this technology. We hope it will ultimately drive down the cost and time associated with clinical trials, which will benefit patients in the long run.”
Opportunities for future drug development
Hepatitis B virus is currently incurable, and affects over 257 million people worldwide. Development of a cure has been slow because there is no model system in which to test potential therapies.
However, the Imperial team showed that the liver-on-a-chip technology could be infected with hepatitis B virus at physiological levels and had similar biological responses to the virus as a real human liver, including immune cell activation and other markers of infection. In particular, this platform uncovered the virus’s intricate means of evading inbuilt immune responses – a finding which could be exploited for future drug development.
Although this technology is in its early stages, the researchers suggest that it might eventually enable patients to have access to new types of personalised medicine. Rather than using generic cells lines, doctors in the future could potentially use cells from an actual patient and test how they would react to certain drugs for their infection, which may make treatments more targeted and effective.
The benefits of using organs-on-chips
Organs-on-chips house live human cells on scaffolds that are physiologically, mechanically, and structurally similar to the emulated organ. Drugs or viruses are passed through the cells via tubes that simulate blood flow through the body. The living cells used in tests last much longer on the chip than in traditional laboratory methods, and require lower infection doses compared to traditionally used model systems.
Hepatitis B is very infectious and causes liver cancer and cirrhosis. Thus, the researchers say, it was the best virus to use for the first test as its interactions with the immune system and liver cells are complex, but with devastating consequences for the tissues.
Dr Dorner said: “Once we begin testing viruses and bacteria on other artificial organs, the next steps could be to test drug interaction with the pathogens within the organ-on-chip environment.”
Other organs-on-chips currently in use include the heart, kidneys, and lungs. The authors say using these artificial organs for human pathogens could help researchers to better understand the mechanisms of infectious disease, and to observe how the virus and cells in the organ interact. This could lead to new drugs and treatments for a number of diseases affecting different organs in the future.
Learn more: Organ-on-chip technology enters next stage as experts test hepatitis B virus
The Latest on: Artificial human organs
[google_news title=”” keyword=”Artificial human organs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial human organs
- Héma-Québec to become exclusive provider of human tissue donations for hospitalson April 26, 2024 at 3:35 pm
In addition to having a monopoly on blood products in the province, Héma-Québec will soon be solely responsible for the distribution of human tissues for all hospitals in Quebec starting December 2024 ...
- CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplanton April 26, 2024 at 11:02 am
Please replace the photo for release dated April 24, 2024 with the accompanying corrected photo. This press release features multimedia. View the full release here: A) Genetically modified source pig ...
- MIT Technology Reviewon April 26, 2024 at 3:00 am
But when I unboxed my two petunias this week, they were in bad shape, with rotted leaves. And in a day, they were dead crisps. My first attempt to do biotech at home is a total bust, and it cost me ...
- Grandmother gets new lease on life from heart pump, pig kidneyon April 25, 2024 at 5:23 pm
A grandmother on the brink of death received an experimental surgery earlier this month, getting a new heart valve and a kidney from a gene-edited pig ...
- SCOTUS considers whether Idaho abortion ban conflicts with federal law | The Excerpton April 25, 2024 at 11:56 am
Plus: A grand jury has charged Arizona Republicans and former aides to Donald Trump in a scheme to falsely claim he won the state in 2020.
- 14 recent scientific breakthroughson April 24, 2024 at 8:40 am
T cells are integral in the immune system but can become "dysfunctional inside tumors." "The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a ...
- Opinion: It’s time to stop science and product testing on animalson April 24, 2024 at 3:44 am
Science has given us many marvels. Electricity immediately springs to mind, as does the telephone. The remarkable ease with which we’re able to trace our ancestry is utterly astounding, and ...
- Artificial blood: Life saving scienceon April 19, 2024 at 11:52 am
We have traveled to Mars, made working artificial hearts, explored the deepest depths of the Mariana Trench, and sequenced the human genome, and yet, we haven’t been able to make artificial blood. Why ...
- How Is It Possible That Android 18 from Dragon Ball Can Have Children Despite Being Artificial?on April 18, 2024 at 1:41 am
Android 18 in Dragon Ball has a baby together with Krillin. But how did she manage to get pregnant despite being an artificial? We explain it.
- The world’s most advanced long-term artificial heart is on the cusp of implantationon April 17, 2024 at 9:55 pm
Using magnetic levitation technology, the world's first long-term artificial heart won't wear out, age or break. It's small enough for ...
via Bing News